Trypsin inhibitor may increase the formation of GSH conjugates of potentially toxic reactive intermediates in isolated rat hepatocytes

J.A. Sinclair, C.J. Henderson, I.K. Martin, M.H. Grant, J.N.A. Tettey

Research output: Contribution to journalArticle

Abstract

Aims to investigate the effect of liver digestion enzymes on the formation of potentially toxic reactive intermediates in suspensions of isolated rat hepatocytes. Isolated hepatocytes are recognized as one of the most relevant and practical models in drug metabolism and toxicity studies. Several modifications of the original twostage collagenase perfusion technique (Seglen 1972) have been reported for the preparation of hepatocytes. However, there is little information on the effects of the liver digestion enzyme on glutathione (L-g-glutamyl-L-cysteinyl-glycine; GSH) conjugation of potentially reactive intermediates in isolated rat hepatocytes. Results indicate that the presence of trypsin inhibitor in the of isolated rat hepatocytes may increase the formation of GSH conjugates of potentially toxic reactive intermediates. This could have significant implications for the interpretation of metabolism data derived from hepatocytes in suspension.
LanguageEnglish
PagesA24-A25
JournalJournal of Pharmacy and Pharmacology
Volume60
Issue number59
DOIs
Publication statusPublished - 2008

Fingerprint

Trypsin Inhibitors
Poisons
Hepatocytes
cysteinylglycine
Digestion
Suspensions
Liver
Collagenases
Enzymes
Drug-Related Side Effects and Adverse Reactions
Glutathione
Perfusion

Keywords

  • trypsin inhibitor
  • gsh conjugates
  • toxic reactive intermediates
  • rat hepatocytes
  • bioengineering

Cite this

@article{6e30d8e8992043d789057d09ff82c425,
title = "Trypsin inhibitor may increase the formation of GSH conjugates of potentially toxic reactive intermediates in isolated rat hepatocytes",
abstract = "Aims to investigate the effect of liver digestion enzymes on the formation of potentially toxic reactive intermediates in suspensions of isolated rat hepatocytes. Isolated hepatocytes are recognized as one of the most relevant and practical models in drug metabolism and toxicity studies. Several modifications of the original twostage collagenase perfusion technique (Seglen 1972) have been reported for the preparation of hepatocytes. However, there is little information on the effects of the liver digestion enzyme on glutathione (L-g-glutamyl-L-cysteinyl-glycine; GSH) conjugation of potentially reactive intermediates in isolated rat hepatocytes. Results indicate that the presence of trypsin inhibitor in the of isolated rat hepatocytes may increase the formation of GSH conjugates of potentially toxic reactive intermediates. This could have significant implications for the interpretation of metabolism data derived from hepatocytes in suspension.",
keywords = "trypsin inhibitor, gsh conjugates, toxic reactive intermediates, rat hepatocytes, bioengineering",
author = "J.A. Sinclair and C.J. Henderson and I.K. Martin and M.H. Grant and J.N.A. Tettey",
note = "Special Issue: BPC Science Abstracts. Poster Session 1: Drug metabolism",
year = "2008",
doi = "10.1211/002235708785623534",
language = "English",
volume = "60",
pages = "A24--A25",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
number = "59",

}

Trypsin inhibitor may increase the formation of GSH conjugates of potentially toxic reactive intermediates in isolated rat hepatocytes. / Sinclair, J.A.; Henderson, C.J.; Martin, I.K.; Grant, M.H.; Tettey, J.N.A.

In: Journal of Pharmacy and Pharmacology, Vol. 60, No. 59, 2008, p. A24-A25.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Trypsin inhibitor may increase the formation of GSH conjugates of potentially toxic reactive intermediates in isolated rat hepatocytes

AU - Sinclair, J.A.

AU - Henderson, C.J.

AU - Martin, I.K.

AU - Grant, M.H.

AU - Tettey, J.N.A.

N1 - Special Issue: BPC Science Abstracts. Poster Session 1: Drug metabolism

PY - 2008

Y1 - 2008

N2 - Aims to investigate the effect of liver digestion enzymes on the formation of potentially toxic reactive intermediates in suspensions of isolated rat hepatocytes. Isolated hepatocytes are recognized as one of the most relevant and practical models in drug metabolism and toxicity studies. Several modifications of the original twostage collagenase perfusion technique (Seglen 1972) have been reported for the preparation of hepatocytes. However, there is little information on the effects of the liver digestion enzyme on glutathione (L-g-glutamyl-L-cysteinyl-glycine; GSH) conjugation of potentially reactive intermediates in isolated rat hepatocytes. Results indicate that the presence of trypsin inhibitor in the of isolated rat hepatocytes may increase the formation of GSH conjugates of potentially toxic reactive intermediates. This could have significant implications for the interpretation of metabolism data derived from hepatocytes in suspension.

AB - Aims to investigate the effect of liver digestion enzymes on the formation of potentially toxic reactive intermediates in suspensions of isolated rat hepatocytes. Isolated hepatocytes are recognized as one of the most relevant and practical models in drug metabolism and toxicity studies. Several modifications of the original twostage collagenase perfusion technique (Seglen 1972) have been reported for the preparation of hepatocytes. However, there is little information on the effects of the liver digestion enzyme on glutathione (L-g-glutamyl-L-cysteinyl-glycine; GSH) conjugation of potentially reactive intermediates in isolated rat hepatocytes. Results indicate that the presence of trypsin inhibitor in the of isolated rat hepatocytes may increase the formation of GSH conjugates of potentially toxic reactive intermediates. This could have significant implications for the interpretation of metabolism data derived from hepatocytes in suspension.

KW - trypsin inhibitor

KW - gsh conjugates

KW - toxic reactive intermediates

KW - rat hepatocytes

KW - bioengineering

UR - http://dx.doi.org/10.1211/002235708785623534

U2 - 10.1211/002235708785623534

DO - 10.1211/002235708785623534

M3 - Article

VL - 60

SP - A24-A25

JO - Journal of Pharmacy and Pharmacology

T2 - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 59

ER -